BIOCERES CROP SOLUTIONS CORP

NASDAQ: BIOX (Bioceres Crop Solutions Corp.)

最近更新时间: 13小时之前

0.173

-0.01 (-5.41%)

前收盘价格 0.183
成交量 130,225
平均成交量 (3个月) 304,617
市值 11,040,149
价格/销量 (P/S) 0.050
股市价格/股市净资产 (P/B) 0.370
52周波幅
0.162 (-6%) — 1.73 (901%)
利润日期 12 Nov 2026
营业毛利率 -118.28%
营业利益率 (TTM) -8.06%
稀释每股收益 (EPS TTM) -1.20
季度收入增长率 (YOY) -30.40%
季度盈利增长率 (YOY) 32.40%
总债务/股东权益 (D/E MRQ) 991.88%
流动比率 (MRQ) 0.700
营业现金流 (OCF TTM) 46.39 M
杠杆自由现金流 (LFCF TTM) 43.49 M
资产报酬率 (ROA TTM) -1.97%
股东权益报酬率 (ROE TTM) -56.80%

AIStockmoo 评分

-4.6
资本回报低于资本成本。资本回报下降。 参考
负债高。盈利能力弱。短期流动性偏紧。现金流为正。 参考
来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 NA
相对估值 参考 NA
隐含增长 参考 NA
历史估值 参考 NA
持仓估值 参考 NA
风险溢价 参考 NA
市场估值 参考 NA
过去一年呈下降趋势。股价远低于52周高点。 参考
下降趋势:股价位于均线之下,均线向下。股价接近均线。 参考
来自我们对走势图的 AI 技术分析。 参考 NA
K线形态 参考 NA
近期没有目标价,因此依据目标价的调整方向。 参考
持仓情绪 参考 NA
新闻情绪 参考 NA
机构在最新13F申报中净-2.42%的股份:6家增持,15家减持(截至30 Sep 2026的季度)。 参考
空头持仓从31 Aug到30 Oct 2026变化+39.8%,回补天数1.7天(FINRA)。 参考
内部交易活动 参考 NA
市场环境偏谨慎。 参考
行业表现落后大市。
各支柱方向一致,评分因此加强。
每股盈利大多下降。近年曾亏损。 参考
低于中期趋势线。 参考
股价低于其52周平均水平。5年来下跌。 参考
短、中、长期趋势均向下。短期动能下降。 参考
支撑与阻力没有明确信号。 参考
最终评分 -4.62
全部展开

市场趋势

短期 中期
行业 Agricultural Inputs (US) 混合的 混合的
Agricultural Inputs (全球的) 混合的 混合的
股票 Bioceres Crop Solutions Corp. 混合的 看跌

相关股票

股票 市值 DY P/E(TTM) P/B 评分
BIOX 11 M - - 0.370 -4.6
LVRO 35 M - - - -1.6
SEED 9 M - - - -4.3
NITO 3 M - - - 0.0
NXTS - - - 0.280 -2.4

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

部门 Basic Materials
行业 Agricultural Inputs
投资方式 Small Core
内部持股比例 16.85%
机构持股比例 21.55%

所有权

姓名 日期 持有股份
Solel Partners Lp 30 Jun 2026 4,579,364
One Degree Advisors Inc 30 Sep 2026 23,038

该时间范围内无数据。

机构

机构持股比例: 11.61%

持仓变动 机构数 股数
增持 6 143,498
减持 15 1,155,560
新建仓 5 143,179
清仓 8 680,815

来源:经Nasdaq的SEC 13F申报,最新申报截至30 Sep 2026。申报在每季结束后45天内陆续提交。

空头持仓

结算日 股数 回补天数
30 Oct 2026 458,064 1.7
15 Oct 2026 852,535 6.6
30 Sep 2026 923,789 3.2
15 Sep 2026 452,852 1.9
31 Aug 2026 327,738 1.0
14 Aug 2026 913,482 4.9

来源:经Nasdaq的FINRA空头持仓数据,每月公布两次。

0 正面 0 负面 2 中性
日期 类型 细节
11 Nov 2026 Yahoo Finance Bioceres Crop: Fiscal Q1 Earnings Snapshot
ROSARIO, Argentina (AP) — ROSARIO, Argentina (AP) — Bioceres Crop Solutions Corp. (BIOX) on Wednesday reported a loss of $9…
11 Nov 2026 Yahoo Finance Bioceres Crop Solutions Reports Fiscal First Quarter 2027 Financial and Operational Results
ROSARIO, Argentina, November 11, 2026--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results…
02 Nov 2026 Yahoo Finance MustGrow Appoints Kevin Helash as Chief Executive Officer
Saskatoon, Saskatchewan--(Newsfile Corp. - November 2, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, today announced the appointment of Kevin Helash as Chief Executive…
28 Oct 2026 Yahoo Finance Deutsche Bank turns bullish on bioMérieux as early flu season eases guidance risk
Investing.com -- Deutsche Bank upgraded French diagnostics company bioMérieux to "buy" from "hold" and raised its price target to €103 from €75, saying an earlier start to the U.S. flu season has reduced the risk to the company’s 2026 guidance.
15 Sep 2026 Yahoo Finance Bioceres Crop Solutions Corp (BIOX) (Q4 2026) Earnings Call Highlights: Q4 Revenue Stabilizes ...
Bioceres Crop Solutions Corp (BIOX) posted flat Q4 revenue of $55.9 million and positive adjusted EBITDA, but full-year sales fell 18% amid litigation and a leveraged balance sheet.
15 Sep 2026 Yahoo Finance Bioceres (BIOX) Q4 2026 Earnings Call Transcript
CEO reports stabilized Argentina operations and $20M cost cuts amid 18% revenue decline.
15 Sep 2026 Yahoo Finance Bioceres Crop Solutions Corp. Q4 2026 Earnings Call Summary
Moby summary of Bioceres Crop Solutions Corp.'s Q4 2026 earnings call…
14 Sep 2026 Yahoo Finance Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
ROSARIO, Argentina, September 14, 2026--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial…
09 Sep 2026 Yahoo Finance Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time
ROSARIO, Argentina, September 09, 2026--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will…

技术形态 中期

趋势排列
斜率
入场位置
成交量
下降趋势:股价位于均线之下,均线向下。股价接近均线。
最近阻力: 0.182 – 0.218 · 强

AI 技术分析

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

风险 / 回报
TP1:
TP2:

以入场价计算,止损的亏损相对每个目标价的盈利。通常追求 2 或以上的比率。

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票